¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023³â Á¦7Â÷ ³»°úºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-01

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023³â Á¦7Â÷ ³»°úºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-01
±³À°ÀÏÀÚ : 2024-06-01
±³À°Àå¼Ò : ¼­¿ï ½ºÀ§½º±×·£µåÈ£ÅÚ

±³À°ÁÖÁ¦ : 2023³â Á¦7Â÷ ³»°úºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À°

ÁÖÃÖ±â°ü : ´ëÇѳ»°úÇÐȸ
¿¬¶ôó : 02-793-4364  

À̸ÞÀÏ : kaim4364@kaim.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 1500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 27 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 80,000¿ø  

ºñ°í "³»°úȸ¿ø: »çÀüµî·Ï - 50,000¿ø / ´çÀϵî·Ï 60,000¿ø

ºñȸ¿ø(Ÿ°ú): »çÀüµî·Ï - 70,000¿ø / ´çÀϵî·Ï 80,000¿ø" 


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 13:30~13:55 Diagnosis and Management of Functional Dyspepsia ¿ÀÁ¤È¯(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 13:55~14:15 Diagnosis and Management of Eosinophilic Esophagitis Á¤±â¿í(¿ï»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 14:15~14:40 Diagnosis and Treatment of Functional Constipation À±Áø¿µ(°æÈñÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 14:40~15:00 Recent Update on the Management of Inflammatory Bowel Disease ¼ÛÀº¹Ì(ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 15:30~15:55 Recent Update on the Management of Steatotic Liver Disease ÀÌÀç½Â(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 15:55~16:15 Simplified Treatment for Hepatitis C Virus ÀÌÇѾÆ(ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 16:15~16:40 Diagnosis and Management of Gallstone Diseases ·ù±âÇö(°Ç¾çÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 16:40~17:00 Recent Update on the Management of Biliary Tract Cancer ÃÖÁøÈ£(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 08:30~09:00 Current Guidelines for Heart Failure À±Á¾Âù(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 09:00~09:30 Current Guidelines for Hypertension         ÀÌÂùÁÖ (¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 09:30~10:00 Current Guidelines for Acute Coronary Syndrome À±ÇõÁØ(°è¸íÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 10:30~11:00 Update on Atrial Fibrillation °íÁ¡¼®(¿ø±¤ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 11:00~11:30 Update on Valvular Heart Disease ¼ÕÁ¤¿ì(¿¬¼¼¿øÁÖÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 11:30~12:00 Update on Bradyarrhythmia ¹ÚÁ¾¼º(µ¿¾ÆÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 13:30~14:00 FeNO/IOS ÀÌ Çö( ÇѾçÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 14:00~14:30 Transbronchial Biopsy for Peripheral Lung Lesions ¾öÁß¼·(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 14:30~15:00 Thoracic Ultrasound ¾ÈÅÂÁØ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 15:30~16:00 Update on Inhaler Treatment for Chronic Airway Disease ½Å¼±Çý (°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 16:00~16:30 Update of PPF: Diagnosis and Treatment ÀÌÀçÇÏ(ÀÎÁ¦ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 16:30~17:00 Immunotherapy for Non-Small Cell Lung Cancer ±è¹ÌÇö(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 5°­ÀÇ½Ç 08:30~09:00 Diagnosis and Management of Diabetes; Lesson from Recent Guidelines °­½Å¾Ö(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 5°­ÀÇ½Ç 09:00~09:30 Novel Role of Mineralocorticoid Receptor Inhibition in the Treatment of Diabetic Kidney Disease ±è³­Èñ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 5°­ÀÇ½Ç 09:30~10:00 CGM and Automated Insulin Delivery Áø»ó¸¸(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 5°­ÀÇ½Ç 10:30~11:00 Discrimination of Secondary Osteoporosis À̽ÂÈÆ(¿ï»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 5°­ÀÇ½Ç 11:00~11:30 Treatment Guidelines for Hypoparathyroidism ¾È¼ºÈñ(ÀÎÇÏÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 5°­ÀÇ½Ç 11:30~12:00 Recent Update for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis ¹Ú¼Ò¿µ(°æÈñÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 3°­ÀÇ½Ç 13:30~14:00 Basic Overview of Electrolytes and Acid-Base Balance in Renal Physiology ÀåÇý·Ã(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 3°­ÀÇ½Ç 14:00~14:30 Sodium and Water Balance Disorder ¹®ÁÖ¿µ(°æÈñÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 3°­ÀÇ½Ç 14:30~15:00 Potassium Disorder in Hospitalized and Critically ill Patients °íÀº½Ç(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 3°­ÀÇ½Ç 15:30~16:00 High Anion-Gap Metabolic Acidosis ±Ç¼ø±æ(ÃæºÏÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 3°­ÀÇ½Ç 16:00~16:30 Acid-Base Disorders in Hospitalized and Critically ill Patients °­¼®ÈÖ(¿µ³²ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 3°­ÀÇ½Ç 16:30~17:00 Metabolic Acidosis in Patients with CKD ±èÀÏ¿µ(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 08:30~09:00 Recent Advances in AML ¹Ú¿ë(°í·ÁÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 09:00~09:30 Recent Advances in MPN È«ÁؽÄ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 09:30~10:00 Recent Advances in MM ±è°æÇÏ(¼øõÇâÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 10:30~11:00 Biomarker in solid tumor using liquid biopsy ±è¸í½Å(°¡Å縯ÀÇ´ë Áø´Ü°Ë»çÀÇÇаú)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 11:00~11:30 Application of ct DAN in clinical practice Â÷¿ëÁØ(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 11:30~12:00 Different signal of PD-L1 in solid tumor as biomarker Á¤¹Î±Ô(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 13:30~14:00 Current Update on Diagnostic approach of Infectious Diseases ¹Ú¼º±Õ(°è¸íÀÇ´ë Áø´Ü°Ë»çÀÇÇаú)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 14:00~14:30 How to use Recently Approved Broad Spectrum Beta-lactams? À±¿µ°æ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 14:30~15:00 Long-awaited novel antibiotics still not introduced in Korea ÀÌÈ¿Áø(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 15:30~16:00 Adult Immunization Policy in Korea ÇãÁß¿¬(¾ÆÁÖÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 16:00~16:30 Guidelines on the Diagnosis and Treatment of Diabetes-related Foot Infections ÃÖÀç±â(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 16:30~17:00 Management of Endocarditis:  2023 ESC Guidelines for the Management of Endocarditis Á¶µ¿È£(¸íÁöº´¿ø)

±³À°½Ã°£ 06¿ù 01ÀÏ 3°­ÀÇ½Ç 08:30~09:15 Implementing Anti-Inflammatory Reliever Strategies in Mild to Moderate Asthma ÀÌÁöÈ£(¿¬¼¼¿øÁÖÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 3°­ÀÇ½Ç 09:15~10:00 Management and New Targeted Therapies in Chronic Cough ±è¹ÎÇý(ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 3°­ÀÇ½Ç 10:30~11:00 Drug Allergy Delabeling in Clinical Practice ±è¼º·Ä(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 3°­ÀÇ½Ç 11:00~11:30 Advances in Mechanisms and Management  of Delayed Drug Hypersensitivity Reaction ½É´Ù¿î(Àü³²ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 3°­ÀÇ½Ç 11:30~12:00 Current and Future Management of Chronic Spontaneous Urticaria and Chronic Inducible Urticaria ÀÌÁöÇâ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 08:30~09:00 Update of Osteoarthritis & Osteoporosis ±èÇö¾Æ(¾ÆÁÖÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 09:00~09:30 Novel Treatments in Inflammatory Myopathy ¹®¼öÁø(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 09:30~10:00 Update of Rheumatoid Arthritis õÀ±È«(°æ»óÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 10:30~11:00 Corticosteroid-Free Adalimumab-Cyclophosphamide Combination Therapy for Acute Phase Neuro-Behçet¡¯s Disease Ç¥Á¤À±(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 11:00~11:30 Immunoglobulin G4-Related Hypertrophic Pachymeningitis with an Isolated Scalp Mass Mimicking a Brain Tumor ÃÖÈ¿Áø(°¡ÃµÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 11:30~12:00 Fatal Hemorrhagic Polymyositis Á¤Á¾Çõ(¿ø±¤ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023³â Á¦7Â÷ ³»°úºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-01""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ÀüºÏÁöȸ Á¦12ȸ ¿¬¼ö°­Á : 2024-06-01
´ÙÀ½±Û Á¦516Â÷ ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ºÎ»ê¡¤¿ï»ê¡¤°æ³²Áöȸ Çмú´ëȸ : 2024-06-01
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21009 ºÎ»ê ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ ºÎ»ê°æ³²Áöȸ Çмúȸ : 2024-06-25 0 3 16:31:46
21008 °æ³² â¿ø½Ã ¼Ò¾Æû¼Ò³â°úÁöȸ ¿¬¼ö°­ÁÂ(¼Ò¾Æ ¼ÒÈ­±â Áúȯ) : 2024-06-25 0 3 16:29:21
21007 Ãæ³² ´Ü±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú °³¿øÀÇ Çмúȸ(±¸°­°ÇÁ¶Áõ) : 2024-06-25 0 3 16:27:43
21006 ¼­¿ï (¿Â¶óÀÎ) 2024³â 6¿ù ¼Ò¾Æ½ÉÃÊÀ½ÆÄ Áý´ãȸ : 2024-06-24 0 3 16:26:02
21005 °æ±â 2024³â ¼Ò¾Æ¼ö¸é¿¬±¸È¸ Á¦2Â÷ Áý´ãȸ(¿Â¶óÀÎ) : 2024-06-24 0 1 16:24:31
21004 Ãæ³² ´Ü±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú (¿Â¶óÀÎ) 29th Vestibular Function Test Workshop : 2024-06-23 0 2 16:20:41
21003 ¼­¿ï ´ëÇѳëÀο©¼ºÀÇÇÐȸ Á¦33Â÷ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö°­Á : 2024-06-23 0 0 16:19:16
21002 ¼­¿ï ´ëÇÑÁ¤ÇüÅëÁõÀÇÇÐȸ - Á¦5ȸ ½ÉÈ­ ½ÉÆ÷Áö¾ö : 2024-06-23 0 1 16:17:49
21001 ºÎ»ê ´ëÇÑÁ·ºÎÁ·°üÀýÇÐȸ - Á¦19Â÷ Çмú´ëȸ : 2024-06-23 0 1 16:16:20
21000 ¼­¿ï 2024³â 6¿ù ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ ¿¬¼ö°­Á : 2024-06-23 0 2 16:13:12
20999 ¼­¿ï Á¦ 10ȸ ´ëÇÑ»êºÎÀΰúÃÊÀ½ÆÄÇÐȸ ¼­¿ïÁöȸ ¿¬¼ö°­Á : 2024-06-23 0 0 16:11:48
20998 ¼­¿ï ´ëÇѵÎÅëÇÐȸ 2024³â Ãá°èÇмú´ëȸ : 2024-06-23 0 1 16:04:24
20997 ´ë±¸ 2024³â ´ëÇѼÒÈ­±âÇÐȸ ´ë±¸°æºÏÁöȸ ¿¬¼ö°­Á : 2024-06-23 0 0 16:02:48
20996 °æ±â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ °æÀÎÁöȸ Á¦7ȸ °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-23 0 8 2024-06-16
20995 ¼­¿ï Á¦18ȸ ´ëÇѺñ°úÇÐȸ ½ÉÆ÷Áö¾ö : 2024-06-23 0 6 2024-06-16
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷